11 terminated. 11 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Terminated 11 |
| Phase 1 | 1 | Terminated 1 |
Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) Interleukin-7, PLACEBO - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 4 | 2021-03-01 | 2024-04-12 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) CYT107, Placebo - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 10 | 2020-12-20 | 2024-04-11 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) CYT107, Placebo - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 26 | 2020-09-15 | 2022-04-08 |
| Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection Thymalfasin - Covid19 | Phase 2 | Terminated | Rhode Island Hospital | 56 | 2020-09-10 | 2023-02-14 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort Interleukin-7, Placebo - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 34 | 2020-06-08 | 2022-04-08 |
| InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort Interleukin-7, Placebos - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 35 | 2020-05-14 | 2022-04-07 |
| Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients CYT107, Placebos - Sepsis, Severe | Phase 2 | Terminated | Revimmune | 21 | 2019-06-01 | 2021-10-27 |
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission | Phase 2 | Terminated | Roswell Park Cancer Institute | 31 | 2017-12-07 | 2025-07-04 |
| Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients Promacta, blood drawing in patients with WAS, blood drawing in healthy controls - Wiskott-Aldrich Syndrome, Thrombocytopenia | Phase 2 | Terminated | Weill Medical College of Cornell University | 24 | 2009-06-01 | 2019-03-18 |
| Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE) CYT107 - Idiopathic CD4+ T-Lymphocytopenia | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 21 | 2009-02-01 | 2015-10-15 |
| Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells Cyclophosphamide Dose Level 1, Cyclophosphamide Dose Level 2, Cyclophosphamide Dose Level 3 - Stem Cell Transplantation, Bone Marrow Transplantation | Phase 2 | Terminated | Children's Hospital Los Angeles | 20 | 2007-02-01 | 2017-02-27 |
COVID-19 (6) · Wiskott-Aldrich Syndrome (3) · Anemia, Diamond-Blackfan (2) · Granulomatous Disease, Chronic (2) · Thalassemia (2) · Anemia, Aplastic (1) · Anemia, Sickle Cell (1) · Congenital amegakaryocytic thrombocytopenia (1) · Genetic Diseases, Inborn (1) · Hemoglobinuria, Paroxysmal (1) · Hemorrhage (1) · Immunologic Deficiency Syndromes (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
Cytopenia (11) · Hematologic Diseases (11) · Hemic and Lymphatic Diseases (11) · Immune System Diseases (11) · Leukocyte Disorders (11) · Leukopenia (11) · Immunologic Deficiency Syndromes (10) · Infections (7) · Coronaviridae Infections (6) · Coronavirus Infections (6) · Lung Diseases (6) · Nidovirales Infections (6) · Pneumonia (6) · Pneumonia, Viral (6) · RNA Virus Infections (6)
Interleukin-7 (5) · Sodium Chloride (5) · Cyclophosphamide (2) · Blood Specimen Collection (1) · Peripheral Blood Stem Cell Transplantation (1) · Saline Solution (1) · Thymalfasin (1) · Trace amine-associated receptor 1 (1) · Whole-Body Irradiation (1) · eltrombopag (1) · fludarabine phosphate (1)
Revimmune (6) · Children's Hospital Los Angeles (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Rhode Island Hospital (1) · Roswell Park Cancer Institute (1) · Weill Medical College of Cornell University (1)
United States (7) · France (2) · Brazil (1) · United Kingdom (1)
Eleftherios Mylonakis, MD PhD FIDSA (1) · James B Bussel, MD (1) · Manu Shankar-Hari, MD PhD (1) · Marcel van den Brink, MD, PhD (1) · Neena Kapoor, M.D. (1) · Philip McCarthy, MD (1) · Richard Hotchkiss, MD (1) · Richard Hotchkiss, MD PhD (1) · Steve Pastores, MD (1) · Virginia M Sheikh, M.D. (1)
PMID 39903535, PMID 32031570, PMID 32171076, PMID 29515037, PMID 23053510, PMID 18946659, PMID 25459642, PMID 26224646, PMID 26675348, PMID 36056913, PMID 36906875